CLOV
Price
$2.79
Change
-$0.05 (-1.76%)
Updated
Jun 26, 04:59 PM (EDT)
Capitalization
381.23M
46 days until earnings call
NEUE
Price
$6.83
Change
-$0.02 (-0.29%)
Updated
Jun 26, 04:58 PM (EDT)
Capitalization
52M
Interact to see
Advertisement

CLOV vs NEUE

Header iconCLOV vs NEUE Comparison
Open Charts CLOV vs NEUEBanner chart's image
Clover Health Investments
Price$2.79
Change-$0.05 (-1.76%)
Volume$163.93K
Capitalization381.23M
NeueHealth
Price$6.83
Change-$0.02 (-0.29%)
Volume$128
Capitalization52M
CLOV vs NEUE Comparison Chart in %
Loading...
CLOV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NEUE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLOV vs. NEUE commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLOV is a Buy and NEUE is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (CLOV: $2.74 vs. NEUE: $6.84)
Brand notoriety: CLOV and NEUE are both not notable
Both companies represent the Managed Health Care industry
Current volume relative to the 65-day Moving Average: CLOV: 117% vs. NEUE: 25%
Market capitalization -- CLOV: $381.23M vs. NEUE: $52M
CLOV [@Managed Health Care] is valued at $381.23M. NEUE’s [@Managed Health Care] market capitalization is $52M. The market cap for tickers in the [@Managed Health Care] industry ranges from $451.47B to $0. The average market capitalization across the [@Managed Health Care] industry is $68.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLOV’s FA Score shows that 0 FA rating(s) are green whileNEUE’s FA Score has 0 green FA rating(s).

  • CLOV’s FA Score: 0 green, 5 red.
  • NEUE’s FA Score: 0 green, 5 red.
According to our system of comparison, NEUE is a better buy in the long-term than CLOV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLOV’s TA Score shows that 4 TA indicator(s) are bullish while NEUE’s TA Score has 3 bullish TA indicator(s).

  • CLOV’s TA Score: 4 bullish, 6 bearish.
  • NEUE’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, NEUE is a better buy in the short-term than CLOV.

Price Growth

CLOV (@Managed Health Care) experienced а -7.74% price change this week, while NEUE (@Managed Health Care) price change was -0.15% for the same time period.

The average weekly price growth across all stocks in the @Managed Health Care industry was -1.37%. For the same industry, the average monthly price growth was +1.17%, and the average quarterly price growth was -1.21%.

Reported Earning Dates

CLOV is expected to report earnings on Aug 11, 2025.

NEUE is expected to report earnings on May 09, 2025.

Industries' Descriptions

@Managed Health Care (-1.37% weekly)

Managed healthcare industry focuses on providing health/medical and disability insurance plans, generally intended to reduce the cost of for-profit health care. The insurance products might be provided through employer-paid (fully or partly) insurance and benefit programs, or through Medicare/Medicaid. Some of the largest providers of managed health care include Aetna, Humana Inc., and Cigna, and UnitedHealthcare.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLOV($381M) has a higher market cap than NEUE($52M). NEUE YTD gains are higher at: -7.817 vs. CLOV (-13.016).
CLOVNEUECLOV / NEUE
Capitalization381M52M733%
EBITDA-210.84MN/A-
Gain YTD-13.016-7.817167%
P/E RatioN/AN/A-
Revenue2.03BN/A-
Total Cash243MN/A-
Total Debt4.66MN/A-
TECHNICAL ANALYSIS
Technical Analysis
CLOVNEUE
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
71%
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 4 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
65%
Advances
ODDS (%)
Bullish Trend 7 days ago
81%
Bullish Trend 15 days ago
76%
Declines
ODDS (%)
Bearish Trend 14 days ago
84%
Bearish Trend 24 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
CLOV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NEUE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FACVX35.48N/A
N/A
Fidelity Advisor Convertible Secs A
FKEMX42.33N/A
N/A
Fidelity Emerging Markets K
FNKCX15.34N/A
N/A
Frank Value C
MACHX21.47N/A
N/A
MoA Balanced Fund
FOSCX28.66-0.30
-1.04%
Tributary Small Company Instl

NEUE and

Correlation & Price change

A.I.dvisor tells us that NEUE and CLOV have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NEUE and CLOV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEUE
1D Price
Change %
NEUE100%
-0.15%
CLOV - NEUE
24%
Poorly correlated
-3.52%
CVS - NEUE
21%
Poorly correlated
-1.79%
UNH - NEUE
21%
Poorly correlated
-1.18%
CI - NEUE
21%
Poorly correlated
-0.26%
OSCR - NEUE
21%
Poorly correlated
-4.15%
More